Choose The Fast Lane: Gene Therapy Capabilities For Adeno-Associated Virus And Lentivirus Production Platforms

Viral vector manufacturing demands a clear, dependable roadmap, especially as gene therapies move from early development toward commercialization. Explore an end‑to‑end workflow for both AAV and lentiviral platforms that shows how cell expansion, production, clarification, purification, and final fill come together in a cohesive sequence. Each stage highlights the critical considerations that influence efficiency, such as media selection, upstream optimization, filtration strategy, and regulatory‑ready testing. Learn more about the importance of integrated support, from raw material qualification through scale‑up and viral safety assurance. 

Access the full brochure to see how each component fits into a scalable, high‑quality viral vector workflow.